logo

Corcept Therapeutics Inc (CORT)



Trade CORT now with
  Date
  Headline
10/1/2018 7:15:34 AM Corcept Therapeutics Receives Orphan Designation For Relacorilant As Treatment For Pancreatic Cancer
2/1/2018 8:40:32 AM Corcept Therapeutics Q4 Revenue $53.3 Mln Vs. $23.8 Mln Prior Year